Newsletter
December 2025
Reflections and Milestones: A Year of Progress for GloPID-R
Dear Readers,
As we come to the end of the year, we would like to take a moment to reflect on recent achievements and the collective progress made across the GloPID-R network. This has been a year marked by collaboration, innovation, and important steps forward in global research preparedness.
Earlier this year, the GloPID-R Data Sharing Working Group launched its suite of implementation tools, including a dedicated GloPID-R Data Sharing Implementation Guide — a forward-looking and practical tool to help research funders support their grantees in sharing research data during outbreaks.
We also launched the first Global Research Improving Pandemic Preparedness (GRIPP) coordinated funding call, aimed at strengthening clinical trial readiness in low- and middle-income countries. This initiative directly advances the World Health Organization’s (WHO) Global Action Plan for Clinical Trial Ecosystem Strengthening (GAP-CTS) and supports the commitments outlined by World Health Assembly Resolution 75.8. It also operationalises the goals and principles of the GloPID-R Funders Living Roadmap for Clinical Trial Coordination. We are currently gearing up for the second GRIPP call which is set to launch in 2026.
Read more
GloPID-R news
GloPID-R General Assembly 2025
GloPID-R’s annual General Assembly took place on October 27–28, 2025, in Paris, France, hosted by GloPID-R member organization ANRS MIE. Representatives from GloPID-R Members and Observers across the world gathered to network, review this year’s activities and collaboratively shape the future direction of GloPID-R. Participants explored how the network can continue to strengthen global coordination, accelerate research responses, and build sustainable mechanisms for preparedness. Read more
Pandemic PACT
100 Days Mission Data Dashboard Launch
The Pandemic PACT programme is developing a series of online, interactive data dashboards aligning relevant subsets of its data to key policy and research roadmaps. The 100 Days Mission (100DM) Dashboard is the first dashboard in this series and it has been launched on the Pandemic PACT website this month.
The 100DM implementation is supported by the International Pandemic Preparedness Secretariat and aims to accelerate the development of safe, effective and affordable diagnostics, therapeutics and vaccines within the first 100 days of an emerging health threat. This publicly available interactive dashboard displays data on health investments aligned with the 100DM objectives.
Member news
Global Health EDCTP3Info Day 2026
Global Health EDCTP3 will be hosting an Info Day on Thursday, 5th February, 2026 to inform potential applicants on the calls for proposals under the Work Programme 2026 and provide useful information to develop a strong project proposal. The Info Day, which will take place online from 09:00 to 13:00 (CET) will comprise expert presentations, a Q&A session and include an opportunity to network and find relevant partners and consortia. For more information and registration, click here.
Global Health Innovative Technology Fund (GHIT Fund)Prototype Detection Test for MPox
The GHIT Fund has an investment of approximately JPY 70 million (€386,000) for the development of a prototype detection test for Mpox. The project involves NIPRO CORPORATION, a global comprehensive healthcare company in the medical devices and pharmaceuticals; TBA Co., Ltd, a venture company originating from Tohoku University; the Japan Institute for Health Security (JIHS); the international non-profit organization PATH (USA); and the Institut National de Recherche Biomédicale (INRB). The project seeks to develop a prototype detection test capable of distinguishing clades using the Iso-PAS method—an inexpensive and simple genetic testing technique—and its performance will be evaluated. This will enable easy testing even in facilities with limited infrastructure, facilitating prompt and appropriate treatment while helping to prevent the spread of infection.
French National Research Agency for HIV, viral hepatitis and emerging infectious diseases (ANRS MIE)CORCs Filoviruses WHO and Ebola research priorities, BE READY launch and first Transnational Call
CORCs Filoviruses WHO and Ebola research priorities
Appointed by WHO to lead the Collaborative Open Research Consortium (CORC) on Filoviruses, ANRS MIE continues to strengthen global epidemic preparedness through its role as a WHO Collaborating Center. To identify the next main research priorities on filoviruses, working groups have been established to define key directions within each of the following subfields: treatments, vaccines, pathophysiology and disease models, viral ecology, and diagnostics.
As part of the CORC filovirus, ANRS MIE has also established contact with the CORC coronaviridae, in connection with the two MERS-CoV cases recently reported in France, to strengthen coordination and collaboration.
Funding Calls
Global Health EDCTP3Global Health EDCTP3 to fund global health research and innovation projects
In 2026, Global Health EDCTP3 will fund up to €147 million in research and innovation projects tackling tuberculosis, lower respiratory tract infections, HIV and climate-change-driven infectious diseases, among other topics. The calls for proposals will open for submission by mid-January 2026. For more information, click here.
IDRCCollaborative network for vaccine research and a therapeutic repurposing research platform
Collaborative network for vaccine research in West and East Africa
IDRC is funding a joint call for proposals focused on four priorities: building sustainable vaccine research-and-development capacity; strengthening regulatory systems and harmonization; building community trust in vaccines; and strengthening vaccine delivery systems. The grant amount for this initiative is CAD $1.9 million (€1.18 million approximately) and will be running for a duration of 55 months.
ANRS MIEStart Programme Fellowships 2026 to help fund a year of master’s degree
The ANRS MIE has made supporting the next generation of scientists a strategic priority by mobilising resources and implementing specific actions to encourage their engagement and development within its research scope. The Start Programme encompasses all actions specifically dedicated to support junior researchers. In this context, the “Master’s grants – International Network” call (Fellowships Funding Scheme 2026) aims to award grants to help fund a year of master’s degree for professionals and students from LMICs working or wishing to work on the agency’s thematic areas. This call for applications will follow a two-step process whereby Phase I will take place from 26 November 2025 till 2 February 2026, and Phase II will take place from 16 March 2026 till 14 May 2026.
